# Safety of DW-MSC infusion in patients with low clinical risk COVID-19 infection: a randomized, double-blind, placebo-controlled trial
> Karyana M.

URL kanonis: https://discover.unhas.ac.id/publications/safety-of-dw-msc-infusion-in-patients-with-low-clinical-risk-covid-19-infection
Jurnal / Konferensi: Stem Cell Research and Therapy
Tahun terbit: 2022
DOI: https://doi.org/10.1186/s13287-022-02812-4
ISSN: 17576512
Kuartil SJR: Q1
Citations: 30

## Authors
- Karyana M.

## Abstract
ClinicalTrials.gov, NCT04535856. Registered 2 September 2020, https://clinicaltrials.gov/ct2/show/NCT04535856.

## Keywords
- Medicine
- Tolerability
- Placebo
- Adverse effect
- Clinical trial
- Internal medicine
- Randomized controlled trial
- Coronavirus disease 2019 (COVID-19)
- Pathology
- Alternative medicine
- Infectious disease (medical specialty)
- Disease

---
Sumber: Discover Unhas — RIMS Universitas Hasanuddin.
Saat mengutip, gunakan DOI bila tersedia atau URL kanonis di atas.